Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $35.9B |
| FY2017, ended Dec 31, 2017 | $39.6B |
| FY2018, ended Dec 31, 2018 | $33.9B |
| FY2019, ended Dec 31, 2019 | $37.4B |
| FY2020, ended Dec 31, 2020 | $25.7B |
| FY2021, ended Dec 31, 2021 | $25.0B |
| FY2022, ended Dec 31, 2022 | $21.1B |
| FY2023, ended Dec 31, 2023 | $25.9B |
| FY2024, ended Dec 31, 2024 | $39.1B |
| FY2025, ended Dec 31, 2025 | $45.3B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $54.9B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $39.6B |
| FY2017, ended Dec 31, 2017 | $41.2B |
| FY2018, ended Dec 31, 2018 | $44.4B |
| FY2019, ended Dec 31, 2019 | $47.0B |
| FY2020, ended Dec 31, 2020 | $17.1B |
| FY2021, ended Dec 31, 2021 | $29.9B |
| FY2022, ended Dec 31, 2022 | $50.6B |
| FY2023, ended Dec 31, 2023 | $58.0B |
| FY2024, ended Dec 31, 2024 | $61.6B |
| FY2025, ended Dec 31, 2025 | $63.4B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $71.8B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $4.20B | $3.82B |
| FY2017, ended Dec 31, 2017 | $3.21B | $1.13B |
| FY2018, ended Dec 31, 2018 | $3.94B | $1.85B |
| FY2019, ended Dec 31, 2019 | $4.77B | $3.49B |
| FY2020, ended Dec 31, 2020 | −$12.4B | −$5.69B |
| FY2021, ended Dec 31, 2021 | $280M | $17.0M |
| FY2022, ended Dec 31, 2022 | $1.32B | −$3.00M |
| FY2023, ended Dec 31, 2023 | $4.61B | $1.14B |
| FY2024, ended Dec 31, 2024 | $3.46B | $2.88B |
| FY2025, ended Dec 31, 2025 | $5.00B | $3.84B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $3.29B | $6.47B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.76B |
| FY2017, ended Dec 31, 2017 | $1.81B |
| FY2018, ended Dec 31, 2018 | $1.56B |
| FY2019, ended Dec 31, 2019 | $2.88B |
| FY2020, ended Dec 31, 2020 | $8.31B |
| FY2021, ended Dec 31, 2021 | $7.93B |
| FY2022, ended Dec 31, 2022 | $3.27B |
| FY2023, ended Dec 31, 2023 | $2.74B |
| FY2024, ended Dec 31, 2024 | $3.07B |
| FY2025, ended Dec 31, 2025 | $4.31B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $3.79B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $7.01B |
| FY2017, ended Dec 31, 2017 | $8.44B |
| FY2018, ended Dec 31, 2018 | $9.37B |
| FY2019, ended Dec 31, 2019 | $10.1B |
| FY2020, ended Dec 31, 2020 | $28.0B |
| FY2021, ended Dec 31, 2021 | $25.1B |
| FY2022, ended Dec 31, 2022 | $21.4B |
| FY2023, ended Dec 31, 2023 | $18.6B |
| FY2024, ended Dec 31, 2024 | $15.3B |
| FY2025, ended Dec 31, 2025 | $13.3B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $12.1B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 10.0% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 731M |
| FY2017, ended Dec 31, 2017 | 707M |
| FY2018, ended Dec 31, 2018 | 679M |
| FY2019, ended Dec 31, 2019 | 640M |
| FY2020, ended Dec 31, 2020 | 638M |
| FY2021, ended Dec 31, 2021 | 640M |
| FY2022, ended Dec 31, 2022 | 641M |
| FY2023, ended Dec 31, 2023 | 643M |
| FY2024, ended Dec 31, 2024 | 646M |
| FY2025, ended Dec 31, 2025 | 653M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 658M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.60B | $154M |
| FY2017, ended Dec 31, 2017 | $1.68B | $169M |
| FY2018, ended Dec 31, 2018 | $1.57B | $159M |
| FY2019, ended Dec 31, 2019 | $2.03B | $161M |
| FY2020, ended Dec 31, 2020 | $344M | $119M |
| FY2021, ended Dec 31, 2021 | $0 | $149M |
| FY2022, ended Dec 31, 2022 | $0 | $150M |
| FY2023, ended Dec 31, 2023 | — | $180M |
| FY2024, ended Dec 31, 2024 | — | $236M |
| FY2025, ended Dec 31, 2025 | — | $313M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | — | — |
Valuation
At current price- Market Cap
- $53.6B
- P/E
- 16.3×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.7×
- Price / Book
- 2.4×
- EV / EBITDA
- 7.9×
Growth
Trailing 12 months- Revenue (TTM)
- $71.8B
- Revenue Growth YoY
- 14.1%
- Revenue CAGR 3Y
- 7.8%
- Revenue CAGR 5Y
- 30.0%
- EPS Growth YoY
- −29.3%
- Net Income Growth YoY
- −28.9%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 7.4%
- Net Margin
- 4.6%
- FCF Margin
- 9.0%
- Return on Equity
- 15.9%
Earnings
Trailing 12 months- Net Income
- $3.29B
- EPS (diluted)
- $5.01
- EBITDA
- $7.87B
- Operating Income
- $5.29B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $3.79B
- Total Debt
- $12.1B
- Net Debt
- $8.32B
- Total Assets
- $86.0B
- Total Liabilities
- $63.5B
- Shareholders' Equity
- $22.5B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $8.00B
- Capital Expenditure
- $1.53B
- Free Cash Flow
- $6.47B
Dividends and risk
Last 12 months- Dividend Yield
- 1.0%
- Dividend / Share
- $0.81
- Beta (5Y)
- 1.33
Every ratio is calculated from the company’s reported figures.